Updates from The Motley Fool

Latest updates on Novavax, Inc. from Fool.com.


Stock Performance

NVAX vs. S&P 500 | 2 Year Performance
NVAX 1-Day Stock Chart
NVAX 5-Day Stock Chart
NVAX 1-Month Stock Chart
NVAX 3-Month Stock Chart
NVAX 6-Month Stock Chart
NVAX 1-Year Stock Chart
NVAX 2-Year Stock Chart
NVAX 5-Year Stock Chart
View Interactive NVAX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novavax, Inc..
Current Price: $4.58
Prev Close: $4.58
Open: $4.71
Bid: $4.60
Ask: $4.64
Day's Range: $4.51 - $4.82
52wk Range: $4.08 - $15.01
Volume: 6,333,759
Avg Vol 5,193,308
Market Cap: $1.24B
P/E (ttm): -7.97
EPS (ttm): -$0.60
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Novavax, Inc..
CAPS Rating 2 out of 5
 
308 Outperform
80 Underperform
CAPS All Stars
 
47 Outperform
16 Underperform

How do you think Novavax, Inc. will perform against the market?



You pick for Novavax, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Stanley C. Erck, CEO

100% Approve

Based on 10 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novavax, Inc..

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers